One of the regulatory factors, VEGF, has been demonstrated to play a central role in the development of various ophthalmic diseases including age-related macular degeneration (AMD), and anti-VEGF antibody has been widely used to treat these diseases [10,11]. This evidence concerns the gene VEGFA and age-related macular degeneration.